{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:00:35Z","timestamp":1794236435150,"version":"4.9.0"},"reference-count":99,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1660,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1398-9995.2011.02557.x","type":"journal-article","created":{"date-parts":[[2011,2,14]],"date-time":"2011-02-14T13:06:36Z","timestamp":1297688796000},"page":"818-829","source":"Crossref","is-referenced-by-count":360,"title":["Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI\/ENDA# and GA2LEN\/HANNA*"],"prefix":"10.1111","volume":"66","author":[{"given":"M. L.","family":"Kowalski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Makowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Blanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bavbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bochenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Demoly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. R.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ni\u017cankowska-Mogilnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sanchez-Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"De Weck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Szczeklik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Brockow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,14]]},"reference":[{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1034\/j.1398-9995.2001.t01-1-00001.x","article-title":"A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force","volume":"56","author":"Johansson","year":"2001","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB2|cit2","first-page":"1227","volume-title":"Middleton\u2019s Allergy","author":"Szczeklik","year":"2009"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1081-1206(10)62221-1","article-title":"Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes","volume":"87","author":"Stevenson","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.all.0000173785.81024.33","article-title":"Epidemiology of hypersensitivity drug reactions","volume":"5","author":"Gomes","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1398-9995.1980.tb01730.x","article-title":"Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review","volume":"35","author":"Settipane","year":"1980","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1365-2222.2004.02070.x","article-title":"Self-reported drug allergy in a general adult Portuguese population","volume":"34","author":"Gomes","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1034\/j.1398-9995.2003.00267.x","article-title":"Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland","volume":"58","author":"Kasper","year":"2003","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bmj.328.7437.434","article-title":"Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice","volume":"328","author":"Jenkins","year":"2004","journal-title":"BMJ"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/014556130708600715","article-title":"The prevalence of Samter\u2019s triad in patients undergoing functional endoscopic sinus surgery","volume":"86","author":"Kim","year":"2007","journal-title":"Ear Nose Throat J"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1346-8138.2004.tb00688.x","article-title":"Multiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivity","volume":"31","author":"Erbagci","year":"2004","journal-title":"J Dermatol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1365-2222.2003.01671.x","article-title":"Anaphylaxis: risk factors for recurrence","volume":"33","author":"Mullins","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1081-1206(10)62318-6","article-title":"Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985-1996)","volume":"87","author":"Cianferoni","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB13|cit13","first-page":"182","article-title":"Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions","volume":"17","author":"Quiralte","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2222.2005.2228.x","article-title":"Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs","volume":"35","author":"Asero","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2165\/00002018-200629080-00005","article-title":"Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England","volume":"29","author":"Layton","year":"2006","journal-title":"Drug Saf"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB16|cit16","first-page":"2234","article-title":"The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective","volume":"30","author":"Mockenhaupt","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin. Clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/bmj.1.5949.67","article-title":"Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients","volume":"1","author":"Szczeklik","year":"1975","journal-title":"Br Med J"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2005.12.053","article-title":"The broken balance in aspirin hypersensitivity","volume":"533","author":"Szczeklik","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE Investigators. European network on aspirin-induced asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB22|cit22","first-page":"147","article-title":"Aspirin-sensitive rhinosinusitis and asthma","volume":"19","author":"Kowalski","year":"2007","journal-title":"Clin Allergy Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0091-6749(83)90439-6","article-title":"Aspirin-sensitive rhinosinusitis\/asthma: spectrum of adverse reactions to aspirin","volume":"71","author":"Pleskow","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1440-1843.2005.00740.x","article-title":"Contribution of aspirin-intolerant asthma to near fatal asthma based on a questionnaire survey in Niigata Prefecture, Japan","volume":"10","author":"Yoshimine","year":"2005","journal-title":"Respirology"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1027\/0838-1925.15.6.246","article-title":"Nasal polyposis in aspirin-hypersensitive patients with asthma (aspirin triad) and aspirin-tolerant patients","volume":"6","author":"Kowalski","year":"2003","journal-title":"Allergy Clin Immunol Int - J World Allergy Org"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","article-title":"Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis","volume":"100","author":"Dursun","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-4-431-98349-1_20","volume-title":"Allergy Frontiers: Diagnosis and Health Economics","author":"Kowalski","year":"2009"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","article-title":"EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity","volume":"62","author":"Nizankowska-Mogilnicka","year":"2007","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1081-1206(10)60692-8","article-title":"Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper","volume":"98","author":"Macy","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0091-6749(98)70163-0","article-title":"Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma","volume":"101","author":"Milewski","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2008.09.048","article-title":"Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease","volume":"123","author":"Hope","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1046\/j.1365-2222.2001.01074.x","article-title":"Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients","volume":"31","author":"Celik","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1046\/j.1365-2222.2000.00953.x","article-title":"A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma","volume":"30","author":"Pierzchalska","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000082586","article-title":"A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs","volume":"136","author":"Sanz","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1365-2222.2004.02050.x","article-title":"The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome","volume":"34","author":"Gamboa","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/ACI.0b013e32832d5311","article-title":"Basophil activation tests in the evaluation of immediate drug hypersensitivity","volume":"9","author":"Sanz","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1365-2222.2008.02989.x","article-title":"Involvement of 15-lipoxygenase and prostaglandin EP receptors in aspirin-triggered 15-hydroxyeicosatetraenoic acid generation in aspirin-sensitive asthmatics","volume":"38","author":"Jedrzejczak-Czechowicz","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1398-9995.2005.00836.x","article-title":"Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPITest)","volume":"60","author":"Kowalski","year":"2005","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1081\/JAS-51326","article-title":"Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance","volume":"42","author":"Celik","year":"2005","journal-title":"J Asthma"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0091-6749(77)90106-3","article-title":"Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis","volume":"60","author":"Szczeklik","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0091-6749(95)70290-3","article-title":"Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects","volume":"96","author":"Settipane","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/00151829-200605060-00005","article-title":"Use of nonsteroidal anti-inflammatory drugs in patients with aspirin hypersensitivity : safety of cyclo-oxygenase-2 inhibitors","volume":"5","author":"Kowalski","year":"2006","journal-title":"Treat Respir Med"},{"issue":"Suppl 1","key":"10.1111\/j.1398-9995.2011.02557.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003495-199300461-00024","article-title":"Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin","volume":"46","author":"Bianco","year":"1993","journal-title":"Drugs"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0091-6749(82)90081-1","article-title":"Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period","volume":"69","author":"Pleskow","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11882-009-0023-4","article-title":"Aspirin sensitivity and desensitization for asthma and sinusitis","volume":"9","author":"Stevenson","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1398-9995.2008.01658.x","article-title":"Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300\u2003mg aspirin daily","volume":"63","author":"Rozsasi","year":"2008","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1046\/j.1365-2222.2001.01160.x","article-title":"An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma","volume":"31","author":"Ragab","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2500\/ajr.2008.22.3148","article-title":"Asthma outcomes after endoscopic sinus surgery in aspirin-tolerant versus aspirin-induced asthmatic patients","volume":"22","author":"Awad","year":"2008","journal-title":"Am J Rhinol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jaci.2003.12.323","article-title":"Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma","volume":"113","author":"Mastalerz","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaci.2008.09.005","article-title":"Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4\u2003years","volume":"123","author":"Setkowicz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000222683","article-title":"Association between asthma, rhinitis and NSAID hypersensitivity in chronic urticaria patients and prevalence rates","volume":"150","author":"Isik","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000103996","article-title":"Predictive value of autologous plasma skin test for multiple nonsteroidal anti-inflammatory drug intolerance","volume":"144","author":"Asero","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7326\/0003-4819-140-12-200406150-00009","article-title":"Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction","volume":"140","author":"Messaad","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB54|cit54","first-page":"164","article-title":"Nonsteroidal anti-inflammatory drug hypersensitivity: fable or reality?","volume":"15","author":"Schubert","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/archderm.139.12.1577","article-title":"Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs","volume":"139","author":"Zembowicz","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1081-1206(10)63166-3","article-title":"Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders","volume":"82","author":"Asero","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1081-1206(10)62226-0","article-title":"Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions","volume":"87","author":"Sanchez Borges","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/CRIAI:24:2:189","article-title":"Prevention and treatment of reactions to NSAIDs","volume":"24","author":"Simon","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1067\/mai.2000.104571","article-title":"Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema","volume":"105","author":"Wong","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1398-9995.2009.02178.x","article-title":"EAACI\/GA(2)LEN\/EDF\/WAO guideline: management of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1081-1206(10)62457-X","article-title":"Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria","volume":"85","author":"Asero","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0091-6749(96)70102-1","article-title":"Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients","volume":"98","author":"Quiralte","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1067\/mai.2003.1444","article-title":"Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria","volume":"111","author":"Asero","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1398-9995.1981.tb01842.x","article-title":"Idiosyncrasy to pyrazolone drugs","volume":"36","author":"Czerniawska-Mysik","year":"1981","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/ACI.0b013e32832db943","article-title":"Selective immediate hypersensitivity reactions to NSAIDs","volume":"9","author":"Canto","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1046\/j.1365-2222.1998.00346.x","article-title":"Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens","volume":"28","author":"Kowalski","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2500\/108854199778251799","article-title":"Diagnosis of pyrazolone drug sensitivity: clinical history versus skin testing and in vitro testing","volume":"20","author":"Kowalski","year":"1999","journal-title":"Allergy Asthma Proc"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1067\/mai.2003.163","article-title":"IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone","volume":"111","author":"Himly","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1081-1206(10)62580-X","article-title":"Paracetamol (acetaminophen) hypersensitivity","volume":"85","author":"de Paramo","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1046\/j.1365-2222.1996.d01-300.x","article-title":"Drug-associated anaphylaxis: 20\u2003years of reporting in The Netherlands (1974-1994) and review of the literature","volume":"26","author":"van der Klauw","year":"1996","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1081-1206(10)62748-2","article-title":"Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity","volume":"84","author":"Sanchez-Borges","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1034\/j.1398-9995.2000.00562.x","article-title":"Selective hypersensitivity to diclofenac","volume":"55","author":"del Pozo","year":"2000","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB73|cit73","first-page":"104","article-title":"Alergia a pirazolonas","volume":"22","author":"Rubio","year":"1994","journal-title":"Allergol Immunopathol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1034\/j.1398-9995.2003.00096.x","article-title":"Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients","volume":"58","author":"Gamboa","year":"2003","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1365-2222.2009.03237.x","article-title":"Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients","volume":"39","author":"Gomez","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB76|cit76","doi-asserted-by":"crossref","unstructured":"Pichler WJ Drug hypersensitivity Karger 2007 176 187","DOI":"10.1159\/isbn.978-3-318-01454-9"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1365-2222.2007.02742.x","article-title":"Delayed drug hypersensitivity reactions - new concepts","volume":"37","author":"Posadas","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1517\/14740338.4.5.837","article-title":"Risk of skin reactions when using ibuprofen-based medicines","volume":"4","author":"Sanchez-Borges","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1365-2133.2001.04422.x","article-title":"Current causes of fixed drug eruption in the UK","volume":"145","author":"Savin","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0536.1993.tb03329.x","article-title":"Fixed drug eruption from piroxicam","volume":"28","author":"Gastaminza","year":"1993","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1046\/j.1365-2133.2001.04267.x","article-title":"Fixed drug eruption due to naproxen; lack of cross-reactivity with other propionic acid derivatives","volume":"144","author":"Gonzalo","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1027\/0838-1925.19.2.44","article-title":"Cutaneous hypersensitivity reactions to inhibitors of cyclooxygenase-2. Results of 307 oral provocation tests and review of the literature","volume":"19","author":"S\u00e1nchez-Borges","year":"2007","journal-title":"Allergy Clin Immunol Int - J World Allergy Org"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3346\/jkms.2008.23.3.521","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs","volume":"23","author":"Lee","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB85|cit85","first-page":"80","article-title":"Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests","volume":"19","author":"Torres","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/rheumatology\/25.1.5","article-title":"Pulmonary alveolitis and NSAIDs - fact or fiction?","volume":"25","author":"Weber","year":"1986","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/pmj.79.931.295","article-title":"Recurrent aseptic meningitis due to different non-steroidal anti-inflammatory drugs including rofecoxib","volume":"79","author":"Ashwath","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2125.1999.00869.x","article-title":"Glomerular, tubular and interstitial nephritis associated with non-steroidal anti-inflammatory drugs. Evidence of a common mechanism","volume":"47","author":"Ravnskov","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"385","DOI":"10.5414\/CNP63385","article-title":"COX-2 inhibitors and acute interstitial nephritis: case report and review of the literature","volume":"63","author":"Esteve","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0536.1993.tb04536.x","article-title":"Topical NSAID allergic contact dermatitis. Italian experience","volume":"29","author":"Pigatto","year":"1993","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00002018-200022050-00002","article-title":"Photosensitivity to ketoprofen: mechanisms and pharmacoepidemiological data","volume":"22","author":"Bagheri","year":"2000","journal-title":"Drug Saf"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1034\/j.1600-0536.2002.460606.x","article-title":"Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing","volume":"46","author":"Zedlitz","year":"2002","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0536.1996.tb02237.x","article-title":"Photopatch test reactivity: effect of photoallergen concentration and UVA dosaging","volume":"34","author":"Hasan","year":"1996","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","article-title":"The lymphocyte transformation test in the diagnosis of drug hypersensitivity","volume":"59","author":"Pichler","year":"2004","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.intimp.2005.11.012","article-title":"Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding","volume":"6","author":"French","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2005.06.029","article-title":"Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment","volume":"116","author":"Hunger","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB98|cit98","first-page":"172","article-title":"Evaluation of drug-related hypersensitivity reactions in children","volume":"9","author":"Martin-Munoz","year":"1999","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1111\/j.1398-9995.2011.02557.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1399-3038.2004.00159.x","article-title":"Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood","volume":"15","author":"Sanchez-Borges","year":"2004","journal-title":"Pediatr Allergy Immunol"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.2011.02557.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1398-9995.2011.02557.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T03:56:41Z","timestamp":1625630201000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.2011.02557.x"}},"subtitle":["Hypersensitivity to nonsteroidal anti-inflammatory drugs"],"short-title":[],"issued":{"date-parts":[[2011,2,14]]},"references-count":99,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.2011.02557.x","relation":{},"ISSN":["0105-4538"],"issn-type":[{"value":"0105-4538","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,14]]}}}